DNA methylation analysis of the tumor suppressor gene CDKN2B in Brazilian leukemia patients

Genetics and Molecular Biology

Volumn 31, Issue 3, 2008, Pages 632-638

  Lima, Patrícia Santos Pereira ^a,b   Molffeta, Greice Andreoti ^b   de Araujo, Amélia Góes ^b   Zago, Marco Antônio ^b   da Silva Jr , Wilson Araújo ^b  

^a UNIVERSIDADE ESTADUAL DO SUDOESTE DA BAHIA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

CDKN2B; CpG island; DNA methylation

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; CYCLIN DEPENDENT KINASE INHIBITOR 2B; MESSENGER RNA;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BRAZIL; CHRONIC GRANULOCYTIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; CPG ISLAND; DNA METHYLATION; GENE EXPRESSION PROFILING; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROMOTER REGION; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE;

EID: 55349094309     PISSN: 14154757     EISSN: 16784685     Source Type: Journal    
DOI: 10.1590/S1415-47572008000400005     Document Type: Article

References (30)

1. Agrawal S, Unterberg M, Koschmieder S, Stadt UZ, Brunnberg U, Verbeek W, Buchner T, Berdel WE, Serve H and Muller-Tidow C (2007) DNA methylation of tumor supressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia. Cancer Res 67:1370-7.
2. Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16:6-21.
3. Chim CS, Wong ASY and Kwong YL (2003) Epigenetic inactivation of INK4/ CDK/RB cell cycle pathway in acute leukemia. Ann Hematol 82:738-742.
4. Claus R and Lubbert M (2003) Epigenetic targets in hematopoietic malignancies. Oncogene 22:6489-96.
5. Dracopoli NC, Haine JL, Moir DT, Morton CC, Seidman CE, Seideman JG and Smith DR (1994) Current Protocols in Human Genetics. John Wiley & Sons, New York, 750 pp.
6. Esteller M and Herman JG (2002) Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol 196:1-7.
7. French SW, Dawson DW, Miner MD, Doerr JR, Malone CS, Wall R and Teitell MA (2002) DNA methylation profiling: A new toot for evaluating hematologic malignancies. Clin Immunol 103:217-230.
8. Galm O, Herman JG and Baylin SB (2006) The fundamental role of epigenetics in hematopoietic malignancies. Blood Rev 20:1-13.
9. Garcia-Manero G, Daniel J, Smith TL, Kornblau SM, Lee M-S, Kantarjian HM and Issa J-PJ (2002). DNA methylation of multiple promoter-associated CpG islands in adult acute lymphocytic leukemia. Clin Cancer Res 8:2217-24.
10. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB (1996) Methylation-specific PCR: A novel PCR assay for methylation status of CpGr islands. Proc Natl Acad Sci USA 93:9821-6.
11. INK4B gene alterations in adult patients with precursor B-cell acute lymphoblastic leukaemia is a favourable prognostic factor. Br J Haematol 117:531-40.
12. Issa J-PJ, Baylin SB and Herman JG (1997) DNA methylation changes in hematologic malignancies: Biologic and clinical implications. Leukemia 11: S7-S11.
13. Jones PA (2003) Epigenetics in carcinogenesis and cancer prevention. Ann NY Acad Sci 983:213-9.
14. Jones PA and Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415-28.
15. Kelly LM and Gilliland DG (2002) Genetics of myeloid leukemias. Annu Rev Genomics Hum Genet 3:79-98.
16. Laird PW (2003) The power and the promise of DNA methylation markers. Nat Rev Cancer 3:253-66.
17. Li L-C and Dahiya R (2002) MethPrimer: Designing primers for methylation PCRs. Bioinformatics 18:1427-31.
18. Markus J, Garin MT, Bies J, Galili N, Raza A, Thirman MJ, Beau MML, Rowley JD, Liu PP and Wolff L (2007) Methylation-independent silencing of the tumor suppressor INK4b (p15) by CBFβ-SMMHC in acute myelogenous leukemia with inv (16). Cancer Res 67:992-1000.
19. Melki JR and Clark SJ (2002) DNA methylation changes in leukaemia. Semin Cancer Biol 12:347-57.
20. Melki JR, Vincent PC and Clark SJ (1999) Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Res 59:3730-40.
21. Mukai T and Sekiguchi M (2002) Gene silencing in phenomena related to DNA repair. Oncogene 21:9033-42.
22. Nephew KP and Huang TH-M (2003) Epigenetic gene silencing in cancer initiation and progression. Cancer Lett 190:25-33.
23. Pagliuca A, Gallo P and Lania L (2000) Differential role for Sp1/Sp3 transcriptional factors in the regulation of the promoter activity of multiple cyclin-dependent kinase inhibitor genes. J Cell Biochem 76:360-7.
24. Rush LJ and Plass C (2002) Alterations of DNA methylation in hematologic malignancies. Cancer Lett 185:1-12.
25. Siegmund KD and Laird PW (2002) Analysis of complex methylation data. Methods 27:170-8.
26. Strathdee G and Brown R (2002) Aberrant DNA methylation in cancer: Potential clinical interventions. Exp Rev Mol Med 4:1-17.
27. Toyota M, Kopecky KJ, Toyota M-O, Jair K-W, Willman CL and Issa J-PJ (2001) Methylation profiling in acute myeloid leukemia. Blood 97:2823-9.
28. Verma M and Srivastava S (2002) Epigenetics in cancer: Implications for early detection and prevention. Lancet Oncol 3:755-63.
29. Wong IHN, Ng MHL, Huang DP and Lee JCK (2000) Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: Potential prognostic implications. Blood 95:1942-49.
30. Zago MA, Falcão RP and Pasquine R (2001) Hematologia: Fundamentos e Prática. 1st ed. Ateneu, São Paulo, 1042 pp.